Katy Dodd (@KatyCDodd) header
Katy Dodd (@KatyCDodd) profile picture

Katy Dodd

@KatyCDodd

Neurologist researching Myasthenia Gravis @katycdodd.bsky.social

Joined November 2015
  • Tweets146
  • Following287
  • Followers201
An updated Lumbar Puncture guideline is now available at theabn.org/page/abnguidance with a summary in @PracticalNeuro pn.bmj.com/content/early/202… Updated from 2018, with stronger emphasis on individual bleeding and thrombosis risk, and risk of delay @ABNTrainees #lumbarpuncture
Image from Katy Dodd (@KatyCDodd)
52
What are the immune system changes in refractory Myasthenia Gravis? Read our publication today in Med @NCareCharity @myawareUK @NCAresearchNHS @DNS_UOM @FBMH_UoM @LydiaBeckerIII sciencedirect.com/science/ar…
Image from Katy Dodd (@KatyCDodd)
4
4
214
We're delighted to share the publication of our Cochrane Review: Rituximab for myasthenia gravis This systematic review examined the RCT evidence for this B cell depleting therapy in myasthenia, and is now available via the Cochrane Library. 🔗 cochranelibrary.com/cdsr/doi…
1
1
4
629
#PublicationAlert Hot off the press. Deeply Humbled by the opportunity to collaborate with the top neurologists and neuroscientists in the UK. @covidcns @LivUni @encephalitis @SciReports @NaturePortfolio @BrainIIGroup communities.springernature.c…

Patients with neurological or psychiatric complications of COVID-19 have worse long-term functional...

In this study, we focused on to the functional outcomes of patients affected with neurological complications of COVID-19 and risk factors associated with poor outcomes among the vulnerable group to...

communities.springernature.com
1
11
1
15
1,073
Viva passed with minor corrections 🎉 #PhDone
Image from Katy Dodd (@KatyCDodd)
8
2
33
2,172
Katy Dodd retweeted
Myaware (@myawareUK) profile picture
Myaware@myawareUK1 Oct 2024
During 2024, myaware has provided over £250,000 in grant funding to researchers and specialist nurses. Can you donate £10 so we can continue to support projects like this during our Specialist Nurses' Appeal 2024? myaware.org/Appeal/specialis…
3
4
266
Fantastic to present some of my immune profiling work from @NCAresearchNHS + @LydiaBeckerIII with @MadhviM at #NMSG2024 in New York. Thanks to research funders @myawareUK @NCareCharity @NMSG_news Great to have other @MCCN_UK colleagues here and as usual lots of great networking
Image from Katy Dodd (@KatyCDodd)
5
26
1,024
NEANU 2024 Friday 15th November, afternoon online session *Five things about... Headache MS Seizures Neuromuscular disorders The confused patient Parkinsons neanu.org to book
Image from NEANU 2024 (@NEANU_2024)
NEANU 2024 (@NEANU_2024) profile pictureNEANU 2024@NEANU_202418 Sep 2024
NEANU is BACK for 2024! North of England Acute Neurology Update "Five things about..." neanu.org/ Only £30 for a sterling afternoon of virtual neurological education
4
10
1,203
Important work here from the team @MCCN_UK @salfordco_nhs. This study of more than 1,600 people with multiple sclerosis shows ethnicity & deprivation negatively impact access to disease-modifying therapy for relapsing-remitting #MS doi.org/10.1136/jnnp-2024-33…
2
6
617
Loved #ABN2024 in sunny (for a bit) Edinburgh. Great to present some data from my PhD with @MadhviM @LydiaBeckerIII + @MCCN_UK
Image from Katy Dodd (@KatyCDodd)
1
12
544
So many fascinating talks at #neuroimmune24 symposium, thanks to @BSI_neuroimmune team! Delighted to be awarded best flash talk
Image from Katy Dodd (@KatyCDodd)
1
14
412
Interesting reading here: Addressing ethnic disparities in neurological research in the UK - an example from @covidcns. Authors inc @cjsmithdr @NEANU_2024 @KatyCDodd from @NCAlliance_NHS sciencedirect.com/science/ar…
4
5
840
**New Publication** looking at side effects of immunosuppression for #MyastheniaGravis in the UK. Thanks to everyone involved + @myaware @NCareCharity @NCAresearchNHS @DNS_UOM @FBMH_UoM nmd-journal.com/article/S096…
Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis

Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis

Myasthenia Gravis (MG) is an autoimmune disease, caused by autoantibodies directed against components of the neuromuscular junction, frequently causing disabling muscle weakness. Current treatment...

nmd-journal.com
2
3
1
15
981
We found that azathioprine is more likely to be discontinued than mycophenolate or methotexate due to side effects (mainly liver dysfunction).
Image from Katy Dodd (@KatyCDodd)
1
1
170
Azathioprine is still an important medication in the management of MG. Liver function test rises are often transient and self limiting but we highlight how azathioprine metabolite testing can be used to help adjust the dose.
Image from Katy Dodd (@KatyCDodd)
1
137
Collating the Voice of people living with Autoimmune Diseases (CoVAD 3) Survey. We aim to understand your life so that physicians may understand healthcare interventions needed to improve those with chronic diseases. If you are >18, can you spare 15 mins? surveymonkey.com/r/TV6JF75
Image from Hector Chinoy (@drhectorchinoy)
1
26
29
3,686
Katy Dodd retweeted
Myaware (@myawareUK) profile picture
Myaware@myawareUK29 Feb 2024
🦜Today is Rare Disease Day! 300 million people worldwide have a rare disease...want to share your colours and get involved? Follow this link for info: rarediseaseday.org/ #ihaveheardofmyasthenia
6
5
482
Another great @ManchesterMed Careers Fair. This year joined by @convectuoso111 to chat to the many students interested in neurology about why it's such a great speciality
Image from Katy Dodd (@KatyCDodd)
2
1
11
486
The next talk in our seminar series is on Weds 6th March at 2pm and is a 2-4-1! Presented by our own Katherine Dodd and Bramwell Coulson and hosted by @RiccardoStorch1. Further details on poster - all welcome! 🧠
Image from Division of Neuroscience (@DNS_UOM)
6
2
7
1,717
Load more